Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CNBX

CNBX Pharmaceuticals Inc.

USD

Set alert

Price alert · CNBX

All alert types
0.00 USD 0.00 +100.00%
As of Oct 30, 2026
0.0001 Day range 0.0001
0.00005 52-week range 0.0007
YTD
-50.00%
1 year
-50.00%
Open
0.0001
Prev close
0.0001
Mkt cap
321.15K
Vol
14.49M
Avg vol
6.38M
EPS
0.00
P/E
0.00
More statistics
Low
0.0001
High
0.0001

5D chart

Chart tools
Interval
1m5m15m30m
CNBX five-day price chart0.000.000.000.000.00Oct 26Oct 27Oct 28

Financial health

Altman Z-Score

-3159.66 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 4
  • Return on Equity 4
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.1×
FY 2016: -16.6×FY 2017: -58.3×FY 2018: -29.4×FY 2019: 30.3×FY 2020: -1.9×FY 2021: -9.4×FY 2022: -0.9×FY 2023: -0.0×FY 2024: -0.3×FY 2025: -0.1×
FY 2016 5y median -0.3× FY 2025
P/S 0.0×
FY 2016: 45.7×FY 2017: 19807×FY 2018: 11409×FY 2019: 3499×FY 2020: 3590×FY 2021: 0.0×FY 2022: 139×FY 2023: 0.4×FY 2024: 1.4×FY 2025: 0.0×
FY 2016 5y median 0.4× FY 2025
P/B -0.0×
FY 2016: -11.0×FY 2017: 38.3×FY 2018: 41.4×FY 2019: 2.3×FY 2020: 14.6×FY 2021: 13.0×FY 2022: -2.5×FY 2023: -0.1×FY 2024: -0.1×FY 2025: -0.0×
FY 2016 5y median -0.1× FY 2025
P/FCF -0.3×
FY 2016: -42.8×FY 2017: -114×FY 2018: -37.6×FY 2019: -10.4×FY 2020: -9.0×FY 2021: -9.4×FY 2022: -2.5×FY 2023: -1.3×FY 2024: -0.8×FY 2025: -0.3×
FY 2016 5y median -1.3× FY 2025
EV/EBITDA -4.5×
FY 2016: -18.4×FY 2017: -56.8×FY 2018: -29.1×FY 2019: 25.5×FY 2020: -3.4×FY 2021: -7.9×FY 2022: -1.6×FY 2023: -0.4×FY 2024: -2.4×FY 2025: -4.5×
FY 2016 5y median -2.4× FY 2025
EV/Sales 0.0×
FY 2016: 45.6×FY 2017: 19215×FY 2018: 11264×FY 2019: 3472×FY 2020: 3481×FY 2021: 0.0×FY 2022: 194×FY 2023: 3.3×FY 2024: 11.2×FY 2025: 0.0×
FY 2016 5y median 3.3× FY 2025
FCF Yield -378.0%
FY 2016: -2.3%FY 2017: -0.9%FY 2018: -2.7%FY 2019: -9.6%FY 2020: -11.1%FY 2021: -10.6%FY 2022: -40.4%FY 2023: -75.4%FY 2024: -130.9%FY 2025: -378.0%
FY 2016 5y median -75.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 100.0%FY 2017: -23.5%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 0.0%FY 2022: -564.1%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -249.8%FY 2017: -32616.1%FY 2018: -39670.1%FY 2019: -33567.0%FY 2020: -42517.8%FY 2021: 0.0%FY 2022: -9860.5%FY 2023: -227.0%FY 2024: -448.2%FY 2025: 0.0%
FY 2016 5y median -227.0% FY 2025
Net Margin 0.0%
FY 2016: -272.9%FY 2017: -34022.5%FY 2018: -39335.7%FY 2019: 11510.7%FY 2020: -104331.4%FY 2021: 0.0%FY 2022: -12427.4%FY 2023: -904.5%FY 2024: -534.3%FY 2025: 0.0%
FY 2016 5y median -534.3% FY 2025
ROE 12.6%
FY 2016: 65.7%FY 2017: -65.8%FY 2018: -142.8%FY 2019: 7.7%FY 2020: -423.2%FY 2021: -176.9%FY 2022: 228.1%FY 2023: 183.9%FY 2024: 28.0%FY 2025: 12.6%
FY 2016 5y median 28.0% FY 2025
ROIC 20.9%
FY 2016: 60.1%FY 2017: -63.1%FY 2018: -144.0%FY 2019: -22.4%FY 2020: -172.5%FY 2021: -97.1%FY 2022: -2337.2%FY 2023: 138.2%FY 2024: 49.2%FY 2025: 20.9%
FY 2016 5y median 20.9% FY 2025
ROA -1703.0%
FY 2016: -1294.5%FY 2017: -53.2%FY 2018: -118.6%FY 2019: 7.5%FY 2020: -336.5%FY 2021: -103.7%FY 2022: -459.0%FY 2023: -743.4%FY 2024: -2214.6%FY 2025: -1703.0%
FY 2016 5y median -743.4% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: 0.0%FY 2017: -94.9%FY 2018: 68.9%FY 2019: 2.5%FY 2020: -27.3%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 1269.1%FY 2024: -68.3%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income 53.4%
FY 2016: 47.9%FY 2017: -559.8%FY 2018: -105.4%FY 2019: 13.3%FY 2020: 7.9%FY 2021: 14.6%FY 2022: -13.6%FY 2023: 68.5%FY 2024: 37.4%FY 2025: 53.4%
FY 2016 FY 2025
EPS (diluted) 84.8%
FY 2016: 44.6%FY 2017: -483.3%FY 2018: -77.1%FY 2019: 127.7%FY 2020: -1265.0%FY 2021: 82.0%FY 2022: -66.2%FY 2023: 88.3%FY 2024: 94.5%FY 2025: 84.8%
FY 2016 FY 2025
Free Cash Flow 30.2%
FY 2016: 34.0%FY 2017: -723.7%FY 2018: -194.9%FY 2019: -13.5%FY 2020: 13.9%FY 2021: 12.5%FY 2022: 32.6%FY 2023: 93.3%FY 2024: -118.2%FY 2025: 30.2%
FY 2016 FY 2025

Financial Health

Current Ratio 0.0×
FY 2016: 0.0×FY 2017: 5.0×FY 2018: 3.0×FY 2019: 9.8×FY 2020: 2.0×FY 2021: 1.2×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
Quick Ratio 0.0×
FY 2016: 0.1×FY 2017: 5.2×FY 2018: 3.4×FY 2019: 17.2×FY 2020: 2.4×FY 2021: 1.2×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
Debt / Equity -0.5×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.5×FY 2022: -1.1×FY 2023: -0.7×FY 2024: -0.5×FY 2025: -0.5×
FY 2016 5y median -0.5× FY 2025
Net Debt / EBITDA -4.3×
FY 2016: 0.1×FY 2017: 1.8×FY 2018: 0.4×FY 2019: -0.2×FY 2020: 0.1×FY 2021: 0.2×FY 2022: -0.5×FY 2023: -0.3×FY 2024: -2.1×FY 2025: -4.3×
FY 2016 5y median -0.5× FY 2025
Interest Coverage -6.8×
FY 2016: -10.3×FY 2017: -424×FY 2018: -4470×FY 2019: -180×FY 2020: -374×FY 2021: -1087×FY 2022: -2321×FY 2023: -793×FY 2024: -29.7×FY 2025: -6.8×
FY 2016 5y median -793× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-08-31